Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease
Aging is one of the main risk factors for cardiovascular disease, resulting in a progressive organ and cell decline. This study evaluated a possible joint impact of two emerging hallmarks of aging, leucocyte telomere length (LTL) and common mitochondrial DNA deletion (mtDNA<sup>4977</sup>...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/21/5508 |
id |
doaj-9491879c4ff648189c65c23f5f7028a9 |
---|---|
record_format |
Article |
spelling |
doaj-9491879c4ff648189c65c23f5f7028a92020-11-25T01:18:38ZengMDPI AGInternational Journal of Molecular Sciences1422-00672019-11-012021550810.3390/ijms20215508ijms20215508Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery DiseaseCecilia Vecoli0Andrea Borghini1Silvia Pulignani2Antonella Mercuri3Stefano Turchi4Eugenio Picano5Maria Grazia Andreassi6CNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, ItalyCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, ItalyCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, ItalyCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, ItalyCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, ItalyCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, ItalyCNR Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, ItalyAging is one of the main risk factors for cardiovascular disease, resulting in a progressive organ and cell decline. This study evaluated a possible joint impact of two emerging hallmarks of aging, leucocyte telomere length (LTL) and common mitochondrial DNA deletion (mtDNA<sup>4977</sup>), on major adverse cardiovascular events (MACEs) and all-cause mortality in patients with coronary artery disease (CAD). We studied 770 patients (673 males, 64.8 ± 8.3 years) with known or suspected stable CAD. LTL and mtDNA<sup>4977</sup> deletion were assessed in peripheral blood using qRT-PCR. During a median follow-up of 5.4 ± 1.2 years, MACEs were 140 while 86 deaths were recorded. After adjustments for confounding risk factors, short LTLs and high mtDNA<sup>4977</sup> deletion levels acted independently as predictors of MACEs (HR: 2.2, 95% CI: 1.2−3.9, <i>p</i> = 0.01 and HR: 1.7, 95% CI: 1.1−2.9, <i>p</i> = 0.04; respectively) and all-cause mortality events (HR: 2.1, 95% CI: 1.1−4.6, <i>p</i> = 0.04 and HR: 2.3, 95% CI: 1.1−4.9, <i>p</i> = 0.02; respectively). Patients with both short LTLs and high mtDNA<sup>4977</sup> deletion levels had an increased risk for MACEs (HR: 4.3; 95% CI: 1.9−9.6; <i>p</i> = 0.0006) and all-cause mortality (HR: 6.0; 95% CI: 2.0−18.4; <i>p</i> = 0.001). The addition of mtDNA<sup>4977</sup> deletion to a clinical reference model was associated with a significant net reclassification improvement (NRI = 0.18, <i>p</i> = 0.01). Short LTL and high mtDNA<sup>4977</sup> deletion showed independent and joint predictive value on adverse cardiovascular outcomes and all-cause mortality in patients with CAD. These findings strongly support the importance of evaluating biomarkers of physiological/biological age, which can predict disease risk and mortality more accurately than chronological age.https://www.mdpi.com/1422-0067/20/21/5508major adverse cardiac eventsall-cause mortalityleucocyte telomere lengthmtdna<sup>4977</sup> common deletioncoronary artery disease |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Cecilia Vecoli Andrea Borghini Silvia Pulignani Antonella Mercuri Stefano Turchi Eugenio Picano Maria Grazia Andreassi |
spellingShingle |
Cecilia Vecoli Andrea Borghini Silvia Pulignani Antonella Mercuri Stefano Turchi Eugenio Picano Maria Grazia Andreassi Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease International Journal of Molecular Sciences major adverse cardiac events all-cause mortality leucocyte telomere length mtdna<sup>4977</sup> common deletion coronary artery disease |
author_facet |
Cecilia Vecoli Andrea Borghini Silvia Pulignani Antonella Mercuri Stefano Turchi Eugenio Picano Maria Grazia Andreassi |
author_sort |
Cecilia Vecoli |
title |
Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease |
title_short |
Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease |
title_full |
Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease |
title_fullStr |
Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease |
title_full_unstemmed |
Independent and Combined Effects of Telomere Shortening and mtDNA<sup>4977</sup> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease |
title_sort |
independent and combined effects of telomere shortening and mtdna<sup>4977</sup> deletion on long-term outcomes of patients with coronary artery disease |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2019-11-01 |
description |
Aging is one of the main risk factors for cardiovascular disease, resulting in a progressive organ and cell decline. This study evaluated a possible joint impact of two emerging hallmarks of aging, leucocyte telomere length (LTL) and common mitochondrial DNA deletion (mtDNA<sup>4977</sup>), on major adverse cardiovascular events (MACEs) and all-cause mortality in patients with coronary artery disease (CAD). We studied 770 patients (673 males, 64.8 ± 8.3 years) with known or suspected stable CAD. LTL and mtDNA<sup>4977</sup> deletion were assessed in peripheral blood using qRT-PCR. During a median follow-up of 5.4 ± 1.2 years, MACEs were 140 while 86 deaths were recorded. After adjustments for confounding risk factors, short LTLs and high mtDNA<sup>4977</sup> deletion levels acted independently as predictors of MACEs (HR: 2.2, 95% CI: 1.2−3.9, <i>p</i> = 0.01 and HR: 1.7, 95% CI: 1.1−2.9, <i>p</i> = 0.04; respectively) and all-cause mortality events (HR: 2.1, 95% CI: 1.1−4.6, <i>p</i> = 0.04 and HR: 2.3, 95% CI: 1.1−4.9, <i>p</i> = 0.02; respectively). Patients with both short LTLs and high mtDNA<sup>4977</sup> deletion levels had an increased risk for MACEs (HR: 4.3; 95% CI: 1.9−9.6; <i>p</i> = 0.0006) and all-cause mortality (HR: 6.0; 95% CI: 2.0−18.4; <i>p</i> = 0.001). The addition of mtDNA<sup>4977</sup> deletion to a clinical reference model was associated with a significant net reclassification improvement (NRI = 0.18, <i>p</i> = 0.01). Short LTL and high mtDNA<sup>4977</sup> deletion showed independent and joint predictive value on adverse cardiovascular outcomes and all-cause mortality in patients with CAD. These findings strongly support the importance of evaluating biomarkers of physiological/biological age, which can predict disease risk and mortality more accurately than chronological age. |
topic |
major adverse cardiac events all-cause mortality leucocyte telomere length mtdna<sup>4977</sup> common deletion coronary artery disease |
url |
https://www.mdpi.com/1422-0067/20/21/5508 |
work_keys_str_mv |
AT ceciliavecoli independentandcombinedeffectsoftelomereshorteningandmtdnasup4977supdeletiononlongtermoutcomesofpatientswithcoronaryarterydisease AT andreaborghini independentandcombinedeffectsoftelomereshorteningandmtdnasup4977supdeletiononlongtermoutcomesofpatientswithcoronaryarterydisease AT silviapulignani independentandcombinedeffectsoftelomereshorteningandmtdnasup4977supdeletiononlongtermoutcomesofpatientswithcoronaryarterydisease AT antonellamercuri independentandcombinedeffectsoftelomereshorteningandmtdnasup4977supdeletiononlongtermoutcomesofpatientswithcoronaryarterydisease AT stefanoturchi independentandcombinedeffectsoftelomereshorteningandmtdnasup4977supdeletiononlongtermoutcomesofpatientswithcoronaryarterydisease AT eugeniopicano independentandcombinedeffectsoftelomereshorteningandmtdnasup4977supdeletiononlongtermoutcomesofpatientswithcoronaryarterydisease AT mariagraziaandreassi independentandcombinedeffectsoftelomereshorteningandmtdnasup4977supdeletiononlongtermoutcomesofpatientswithcoronaryarterydisease |
_version_ |
1725141477796872192 |